Lopinavir and Ritonavir

Product NDC
42385-934
11-digit product format
423850934
Labeler code
42385
Product ID
42385-934_3a3c4164-da47-427d-9f12-6d1f73b0729d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lopinavir and Ritonavir
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Laurus Labs Limited
Application
ANDA213857
Marketing category
ANDA
Marketing start
2022-03-22
Substance
LOPINAVIR; RITONAVIR
Active strength
200; 50 mg/1; mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Lopinavir and Ritonavir
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LOPINAVIR200 mg/1
RITONAVIR50 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii2494G1JF75, O3J8G9O825
Rxcui597730, 746645

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1d2364f5-8b1e-7c9a-4518-7b359d95fa50Product name220250116
00d976a9-a12a-db3d-ac4e-27498af714cfProduct name520250115
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
7a5f5ac7-15c0-4d8b-bea4-b3b28cb83a8dProduct name120231023
c8f34825-48cd-e7db-4048-c3be840a9308Product name520230123
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
d1ee4fdb-1116-417b-8889-dc05571445b3Product name120160825
f8d26468-b1dc-49d8-a188-8b5d531405efProduct name120150731
0b1bb9d1-e628-4e7c-aada-fd6532257932Product name120150416
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
96979b26-bb9a-43d8-e3a6-d69b9e9f75e5Product name120140508
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
42385-934-12Lopinavir and Ritonavir120 in 1 BOTTLETABLET, FILM COATED1202

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
42385-934-12EA - Each42385-934b50f9f57-5089-4479-84a9-62e97ef2cfd412022-04-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
42385-934LOPINAVIR AND RITONAVIR TABLET, FILM COATED [LAURUS LABS LIMITED]2Current NDC, Legacy NDC, 1 package rows20231021_a7072c60-6dbf-4125-95e7-497c05a9e6a6.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
746645lopinavir 100 MG / ritonavir 25 MG Oral TabletPSNa7072c60-6dbf-4125-95e7-497c05a9e6a62
597730lopinavir 200 MG / ritonavir 50 MG Oral TabletPSNa7072c60-6dbf-4125-95e7-497c05a9e6a62
746645lopinavir 100 MG / ritonavir 25 MG Oral TabletSCDa7072c60-6dbf-4125-95e7-497c05a9e6a62
597730lopinavir 200 MG / ritonavir 50 MG Oral TabletSCDa7072c60-6dbf-4125-95e7-497c05a9e6a62
597730lopinavir 200 MG / ritonavir 50 MG Oral TabletPSNf63db7e1-71cd-325c-e053-2995a90aa0711
597730lopinavir 200 MG / ritonavir 50 MG Oral TabletSCDf63db7e1-71cd-325c-e053-2995a90aa0711

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
42385-934-1242385093412120 TABLET, FILM COATED in 1 BOTTLE (42385-934-12) 2022-03-220000-00-00NoNoCurrent